28 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• Titan Pharmaceuticals, Inc. TTNP stock surged 40.5% to $0.45 during Friday's pre-market session. The market value of their outstanding shares is at $4.2 million.
• Aclaris Therapeutics, Inc. ACRS shares increased by 19.3% to $1.42. The market cap seems to be at $51.5 million. According to the most recent rating by JMP Securities, on September 06, the current rating is at Market Perform.
• OrganiGram Holdings, Inc. OGI shares increased by 5.9% to $2.88. The market value of their outstanding shares is at $609.9 million.
• BioNTech, Inc. BNTX stock moved upwards by 5.5% to $15.02.
• SELLAS Life Sciences, Inc. SLS shares increased by 4.4% to $0.13. The market cap stands at $27.4 million.
• Cancer Genetics, Inc. CGIX stock rose 4.1% to $0.18. The market cap seems to be at $6.1 million.
• BioLife Solutions, Inc. BLFS stock moved upwards by 3.5% to $15.48. The market cap seems to be at $371.2 million. The most recent rating by Northland Capital Markets, on September 04, is at Outperform, with a price target of $22.00.
• Acasti Pharma, Inc. ACST stock increased by 3.3% to $2.20. The market cap seems to be at $158.2 million. The most recent rating by B. Riley FBR, on August 29, is at Buy, with a price target of $7.75.
• Sierra Oncology, Inc. SRRA stock surged 3.2% to $0.34. The market cap seems to be at $30.2 million.
• Aphria, Inc. APHA stock moved upwards by 2.8% to $4.75. The market cap seems to be at $1.4 billion. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.
• Tilray, Inc. TLRY shares moved upwards by 2.7% to $21.20. The market cap stands at $2.6 billion. The most recent rating by MKM Partners, on September 20, is at Neutral, with a price target of $34.00.
• Aurora Cannabis, Inc. ACB stock increased by 2.1% to $3.80. The market cap seems to be at $4.8 billion. The most recent rating by MKM Partners, on September 20, is at Sell, with a price target of $5.00.
• Amarin Corp, Inc. AMRN stock rose 2.1% to $15.22. The market cap stands at $5.7 billion.
• Geron, Inc. GERN shares increased by 2.1% to $1.47. The market cap stands at $254.3 million. The most recent rating by H.C. Wainwright, on September 03, is at Buy, with a price target of $4.00.
• SmileDirectClub, Inc. SDC shares increased by 1.7% to $10.41. The market value of their outstanding shares is at $6.0 billion. According to the most recent rating by William Blair, on October 07, the current rating is at Outperform.
• Royal Philips, Inc. PHG shares surged 1.6% to $42.56. The market value of their outstanding shares is at $42.0 billion.
• Johnson & Johnson, Inc. JNJ stock increased by 1.5% to $130.89. The market cap stands at $347.1 billion. According to the most recent rating by Bernstein, on October 11, the current rating is at Outperform.
• Sorrento Therapeutics, Inc. SRNE stock increased by 1.4% to $1.48. The market cap seems to be at $280.3 million. The most recent rating by JMP Securities, on October 07, is at Market Outperform, with a price target of $21.00.

Losers

• Viveve Medical, Inc. VIVE shares decreased by 11.1% to $3.20 during Friday's pre-market session. The market value of their outstanding shares is at $2.6 million. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
• Ocugen, Inc. OCGN stock plummeted 6.3% to $1.49. The market value of their outstanding shares is at $4.4 million.
• OncoSec Medical, Inc. ONCS stock plummeted 5.4% to $2.09. The market cap seems to be at $20.9 million.
• SINTX Technologies, Inc. SINT stock plummeted 2.6% to $1.86. The market cap seems to be at $3.9 million.
• AVEO Pharmaceuticals, Inc. AVEO stock fell 2.5% to $0.80. The market value of their outstanding shares is at $153.4 million. The most recent rating by H.C. Wainwright, on September 11, is at Buy, with a price target of $1.75.
• HEXO, Inc. HEXO shares fell 2.5% to $2.76. The market cap stands at $959.9 million. The most recent rating by Bank of America, on October 07, is at Underperform, with a price target of $4.00.
• Advaxis, Inc. ADXS shares plummeted 2.0% to $0.33. The market value of their outstanding shares is at $6.1 million.
• Qiagen, Inc. QGEN stock plummeted 1.6% to $26.80. The market value of their outstanding shares is at $7.4 billion. According to the most recent rating by Kepler Cheuvreux, on October 09, the current rating is at Reduce.
• Canopy Growth, Inc. CGC shares decreased by 1.5% to $20.13. The market value of their outstanding shares is at $8.3 billion. According to the most recent rating by Jefferies, on October 11, the current rating is at Underperform.
• Option Care Health, Inc. BIOS shares declined 1.2% to $3.30. The market cap stands at $2.4 billion. The most recent rating by SunTrust Robinson Humphrey, on September 20, is at Buy, with a price target of $4.25.